Litcius/Paper detail

Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial

Stèphane Gaudry, David Hajage, Laurent Martin‐Lefèvre, Saïd Lebbah, Guillaume Louis, Sébastien Moschietto, Dimitri Titeca‐Beauport, Béatrice La Combe, Bertrand Pons, Nicolas de Prost, Sébastien Besset, Alain Combes, Adrien Robine, Marion Beuzelin, Julio Badié, Guillaume Chevrel, Julien Bohé, Elisabeth Coupez, Nicolas Chudeau, Saber Davide Barbar, Christophe Vinsonneau, Jean-Marie Forel, Didier Thévenin, Éric Boulet, Karim Lakhal, Nadia Aïssaoui, Steven Grangé, Marc Léone, Guillaume Lacave, Saad Nseir, Florent Poirson, Julien Mayaux, Karim Asehnoune, Guillaume Géri, Kada Klouche, Guillaume Thiéry, Laurent Argaud, Bertrand Rozec, Cyril Cadoz, Pascal Andreu, Jean Reignier, Jean‐Damien Ricard, Jean‐Pierre Quenot, Didier Dreyfuss

2021The Lancet268 citationsDOI

Topics & Concepts

MedicineRenal replacement therapyOliguriaAcute kidney injuryRandomized controlled trialPopulationBlood urea nitrogenKidney diseaseSurgeryInternal medicineKidneyRenal functionEnvironmental healthAcute Kidney Injury ResearchTrauma, Hemostasis, Coagulopathy, ResuscitationDialysis and Renal Disease Management
Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial | Litcius